News
Discover the latest news and developments in AI and machine learning happening in the image-guided therapy (IGT) sector in Canada.
Medventions partners with Mitacs to support dozens of medtech entrepreneurship fellowships across Canada
During the Medventions Toronto Innovation Day on June 9, Co-founder and Co-director, Dr. Ahmed Nasef, announced the launch of the Medventions Mitacs Umbrella agreement. This Umbrella will support Medventions fellowship programs across Canada, including in Ontario, Nova Scotia, and Newfoundland and Labrador over the next two years.
Seeing beneath the surface: How MIMOSA is transforming wound care
Dr. Karen Cross, a plastic and reconstructive surgeon and CEO of MIMOSA Diagnostics, saw countless patients with diabetes and chronic wounds in her clinic. People with diabetes have an increased risk of developing pressure wounds due to complications like poor circulation and nerve damage. Many of her patients came into her clinic too late to prevent complications and ultimately had lower extremity amputations to prevent fatal infections.
INOVAIT publishes framework for responsibly unlocking Canadian health data for innovation and better patient care
Industry members in the INOVAIT Network are developing AI technologies that are revolutionizing the diagnosis and treatment of disease and improving patient outcomes while building the Canadian healthcare economy. The health data these companies need to create their technologies most often reside with Canadian healthcare institutions that are reluctant to share data with commercial partners due to caution stemming from a lack of clarity in privacy legislation and historical practices focused primarily on minimizing privacy and security risks.
Network News
Sonic Incytes is making liver screening more accessible
Sonic Incytes, a Canadian artificial intelligence (AI)-assisted medical imaging company based out of Vancouver, British Columbia, is looking to change the way liver disease is screened and monitored globally. Their flagship, FDA cleared device, Velacur™, is revolutionizing the diagnosis and management of chronic liver disease. Their proprietary technology that grew into Velacur was originally developed by researchers at the University of British Columbia (UBC).
INOVAIT’s Pilot Fund now accepting applications for image-guided therapy projects
October 18, 2023 | Toronto, ON – INOVAIT, the pan-Canadian network for image-guided therapy (IGT), is now accepting...
Work in Canada’s IGT sector: IGT companies hiring right now
INOVAIT member companies are looking for talent that could help transform the delivery of healthcare. Could it be you?...
Medical technology fellowship program, established by Sunnybrook in Toronto, launches second program with the Nova Scotia Health Innovation Hub
Medventions, established by Sunnybrook in Toronto, launches second program with the Nova Scotia Health Innovation Hub
IGT Lecture Series
Regulating AI in Image-Guided Therapy
Follow INOVAIT on Social Media
The Network in the Press
